Target intelligence / Profile preview

Small nuclear ribonucleoprotein polypeptide E (SNRPE)

Target
SNRPE
Molecular classification
Other (core component of spliceosomal small nuclear ribonucleoproteins), RNA-binding protein
01

Overview

Small nuclear ribonucleoprotein polypeptide E (SNRPE) is a highly conserved RNA-binding protein, a core component of the U1, U2, U4, and U5 small nuclear ribonucleoproteins (snRNPs) that form the essential building blocks of the spliceosome[2][4][5]. SNRPE plays a critical role in pre-mRNA splicing and 3' end processing of histone pre-mRNAs, and it participates in both major and minor (U12-type) spliceosomes[2][4]. In addition, SNRPE is a key structural and functional constituent of several snRNP complexes and, as part of the U7 snRNP, is involved in histone transcript maturation[3][4]. Disease-associated studies have implicated SNRPE in autoimmunity (notably systemic lupus erythematosus, where it serves as an autoantigen), some congenital disorders of hair development (like hypotrichosis), and cancer, particularly prostate cancer, where SNRPE expression promotes tumor cell proliferation by regulating androgen receptor expression[1][2]. While SNRPE is not currently a target of any approved drugs, its role in splicing and disease makes it a highly relevant protein for molecular biology, cancer biology, and immunology research[1][2][6].

Other names
Small nuclear ribonucleoprotein ESNRPEsnRNP-ESm-ESmESm protein EHYPT11SMEsm protein E
02

Biological functions

pre-mRNA splicing3' end processing of histone transcriptssnRNP assemblyRNA binding
03

Disease associations

Cancer (documented involvement, especially in prostate cancer and potentially in other types)Autoimmune disease (systemic lupus erythematosus, as an autoantigen)Genetic disorder (Hypotrichosis 11 and Hypotrichosis Simplex)
04

Safety considerations

Important for core splicing; inhibition may disrupt global RNA processing, causing toxicityAutoimmunity risk (component of snRNP autoantigen complex in lupus)
05

Biomarkers

SNRPE protein (as an autoantibody target in systemic lupus erythematosus)SNRPE expression (potentially as a biomarker for cancer progression, especially in prostate cancer)

Beyond the preview

Go deeper on Small nuclear ribonucleoprotein polypeptide E (SNRPE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide E (SNRPE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call